{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T07:12:31Z","timestamp":1791616351397,"version":"4.3.4"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T00:00:00Z","timestamp":1776816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020415","name":"Additional Ventures","doi-asserted-by":"publisher","award":["GCS: 112982.1"],"award-info":[{"award-number":["GCS: 112982.1"]}],"id":[{"id":"10.13039\/100020415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL163576"],"award-info":[{"award-number":["R01HL163576"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["R01HL076485"],"award-info":[{"award-number":["R01HL076485"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["P41EB027062"],"award-info":[{"award-number":["P41EB027062"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006474","name":"Columbia University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006474","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["EEC1647837"],"award-info":[{"award-number":["EEC1647837"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bioactmat.2026.04.032","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T14:13:54Z","timestamp":1778249634000},"page":"309-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Modeling ventricular tachycardia in genetic long QT syndrome using engineered cardiac tissues"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3959-5094","authenticated-orcid":false,"given":"Richard Z.","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Doufexi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4098-5580","authenticated-orcid":false,"given":"Marc","family":"Yehya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5511-6105","authenticated-orcid":false,"given":"Margaretha A.J.","family":"Morsink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghai","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Ben-Johny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9382-1574","authenticated-orcid":false,"given":"Gordana","family":"Vunjak-Novakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2026.04.032_bib1","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIR.0b013e31820a55f5","article-title":"Forecasting the future of cardiovascular disease in the United States","volume":"123","author":"Heidenreich","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib2","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(25)01917-8","article-title":"Global burden of 292 causes of death in 204 countries and territories and 660 subnational locations, 1990\u20132023: a systematic analysis for the global burden of disease Study 2023","volume":"406","author":"Naghavi","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib3","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.109.863209","article-title":"Prevalence of the congenital Long-QT syndrome","volume":"120","author":"Schwartz","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib4","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1161\/CIRCULATIONAHA.111.060343","article-title":"An update on channelopathies","volume":"127","author":"Webster","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib5","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(99)02107-8","article-title":"Long QT syndromes and torsade de pointes","volume":"354","author":"Viskin","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib6","doi-asserted-by":"crossref","first-page":"3997","DOI":"10.1093\/eurheartj\/ehac262","volume":"43","author":"Zeppenfeld","year":"2022","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib7","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jacep.2022.02.017","article-title":"Congenital long QT syndrome","volume":"8","author":"Krahn","year":"2022","journal-title":"JACC Clin. Electrophysiol."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib8","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1136\/heartjnl-2020-318259","article-title":"Diagnosis, management and therapeutic strategies for congenital long QT syndrome","volume":"108","author":"Wilde","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.31083\/j.rcm2406170","article-title":"The clinical diagnosis and management of long QT syndrome: insights from the 2022 ESC Guidelines","volume":"24","author":"Wang","year":"2023","journal-title":"Rev. Cardiovasc. Med."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/cpt.205","article-title":"Late sodium current block for drug-induced long QT syndrome: results from a prospective clinical trial","volume":"99","author":"Johannesen","year":"2016","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2024.105108","article-title":"Impacts of gene variants on drug effects-the foundation of genotype-guided pharmacologic therapy for long QT syndrome and short QT syndrome","volume":"103","author":"Zhao","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1186\/s13023-024-03445-x","article-title":"A natural history Study of Timothy syndrome","volume":"19","author":"Timothy","year":"2024","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib13","series-title":"Channelopathies in Heart Disease","first-page":"379","article-title":"Transgenic animal models of cardiac channelopathies: benefits and limitations","author":"Odening","year":"2018"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.00853","article-title":"Transgenic rabbit models in proarrhythmia research","volume":"11","author":"Baczk\u00f3","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib15","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1161\/CIRCRESAHA.122.320258","article-title":"Animal models to Study cardiac arrhythmias","volume":"130","author":"Blackwell","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/s41551-022-00885-3","article-title":"Opportunities and challenges in cardiac tissue engineering from an analysis of two decades of advances","volume":"6","author":"Zhuang","year":"2022","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib17","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa0908679","article-title":"Patient-Specific induced pluripotent stem-cell models for Long-QT syndrome","volume":"363","author":"Moretti","year":"2010","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature09747","article-title":"Modelling the long QT syndrome with induced pluripotent stem cells","volume":"471","author":"Itzhaki","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.15420\/aer.2019.1.1","article-title":"Long QT syndrome modelling with cardiomyocytes derived from human-induced pluripotent stem cells","volume":"8","author":"Sala","year":"2019","journal-title":"Arrhythmia Electrophysiol. Rev."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib20","doi-asserted-by":"crossref","first-page":"eabq6720","DOI":"10.1126\/sciadv.abq6720","article-title":"Modeling long QT syndrome type 2 on-a-chip via in-depth assessment of isogenic gene-edited 3D cardiac tissues","volume":"8","author":"Veldhuizen","year":"2022","journal-title":"Sci. Adv."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib21","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1161\/CIRCRESAHA.122.320496","article-title":"CRISPR modeling and correction of cardiovascular disease","volume":"130","author":"Liu","year":"2022","journal-title":"Circ. Res."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nature09855","article-title":"Using induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome","volume":"471","author":"Yazawa","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.stemcr.2014.06.003","article-title":"Calcium transients closely reflect prolonged action potentials in iPSC models of inherited cardiac arrhythmia","volume":"3","author":"Spencer","year":"2014","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib24","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jacc.2018.04.041","article-title":"Genome editing of induced pluripotent stem cells to Decipher cardiac channelopathy variant","volume":"72","author":"Garg","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib25","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.stemcr.2019.06.007","article-title":"Phenotype-Based high-throughput classification of long QT syndrome subtypes using human induced pluripotent stem cells","volume":"13","author":"Yoshinaga","year":"2019","journal-title":"Stem Cell Rep."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib26","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41467-017-01125-y","article-title":"Modelling Torsade de Pointes arrhythmias in vitro in 3D human iPS cell-engineered heart tissue","volume":"8","author":"Kawatou","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.actbio.2019.05.016","article-title":"Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications","volume":"92","author":"Goldfracht","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41467-019-13868-x","article-title":"Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes","volume":"11","author":"Goldfracht","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib29","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.stem.2020.05.004","article-title":"Human-iPSC-Derived Cardiac stromal cells enhance maturation in 3D Cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease","volume":"26","author":"Giacomelli","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib30","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41586-018-0016-3","article-title":"Advanced maturation of human cardiac tissue grown from pluripotent stem cells","volume":"556","author":"Ronaldson-Bouchard","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib31","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.cell.2018.11.042","article-title":"A platform for generation of chamber-specific cardiac tissues and disease modeling","volume":"176","author":"Zhao","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.107925","article-title":"Metabolic maturation media improve physiological function of Human iPSC-Derived cardiomyocytes","volume":"32","author":"Feyen","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib33","first-page":"e272","article-title":"2017 AHA\/ACC\/HRS Guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2021.668546","article-title":"Update on the molecular genetics of Timothy Syndrome","volume":"9","author":"Bauer","year":"2021","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib35","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/01.CIR.103.1.89","article-title":"Genotype-Phenotype correlation in the Long-QT syndrome","volume":"103","author":"Schwartz","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.cell.2004.09.011","article-title":"CaV1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism","volume":"119","author":"Splawski","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib37","series-title":"Creighton University Ventricular Tachyarrhythmia Database","author":"Nolle","year":"1992"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib38","doi-asserted-by":"crossref","first-page":"e215","DOI":"10.1161\/01.CIR.101.23.e215","article-title":"PhysioBank, PhysioToolkit, and PhysioNet","volume":"101","author":"Goldberger","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2003.04.055","article-title":"Torsade de pointes: the clinical considerations","volume":"96","author":"Gowda","year":"2004","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib40","first-page":"729","article-title":"Distinction of ventricular fibrillation and ventricular tachycardia using cross correlation","volume":"2003","author":"Ruiz","year":"2003","journal-title":"Comput. Cardiol."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib41","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.hrthm.2006.04.024","article-title":"Verapamil decreases ventricular tachyarrhythmias in a patient with Timothy syndrome (LQT8)","volume":"3","author":"Jacobs","year":"2006","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.yjmcc.2022.10.003","article-title":"Impaired CaV1.2 inactivation reduces the efficacy of calcium channel blockers in the treatment of LQT8","volume":"173","author":"Bamgboye","year":"2022","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.scr.2021.102402","article-title":"Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome","volume":"54","author":"Mond\u00e9jar-Parre\u00f1o","year":"2021","journal-title":"Stem Cell Res."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib44","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1172\/JCI19844","article-title":"Long QT syndrome: novel insights into the mechanisms of cardiac arrhythmias","volume":"112","author":"Kass","year":"2003","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib45","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1016\/j.jacc.2011.12.063","article-title":"Nonsustained ventricular tachycardia","volume":"60","author":"Katritsis","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib46","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1093\/cvr\/cvac103","article-title":"Initiation of ventricular arrhythmia in the acquired long QT syndrome","volume":"119","author":"Alexander","year":"2023","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib47","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1242\/dmm.008409","article-title":"Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture","volume":"5","author":"Lahti","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib48","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.889519","article-title":"Deciphering common long QT syndrome using CRISPR\/Cas9 in human-induced pluripotent stem cell-derived cardiomyocytes","volume":"9","author":"Song","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib49","article-title":"FDA\u2019s ISTAND Pilot Program accepts a submission of first organ-on-a-chip technology designed to predict human drug-induced liver injury (DILI)","author":"Center for Drug Evaluation and Research","year":"2024","journal-title":"FDA"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib50","article-title":"FDA announces plan to phase out animal testing requirement for monoclonal antibodies and other drugs","year":"2025","journal-title":"FDA"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib51","series-title":"Roadmap to Reducing Animal Testing in Preclinical Safety Studies","year":"2025"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib52","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.hrthm.2008.11.005","article-title":"Mechanisms of VF maintenance: wandering wavelets, mother rotors, or Foci","volume":"6","author":"Tabereaux","year":"2009","journal-title":"Heart Rhythm Off. J. Heart Rhythm Soc"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib53","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev-physiol-021014-071622","article-title":"Mechanisms of ventricular arrhythmias: from molecular fluctuations to electrical turbulence","volume":"77","author":"Qu","year":"2015","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib54","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202509242","article-title":"Integrating hierarchical vasculature into engineered cardiac tissues","author":"Zhuang","year":"2025","journal-title":"Adv. Mater. Deerfield Beach Fla"},{"key":"10.1016\/j.bioactmat.2026.04.032_bib55","first-page":"21.3.1","article-title":"Chemically defined culture and cardiomyocyte differentiation of human pluripotent stem cells","volume":"87","author":"Burridge","year":"2015","journal-title":"Curr. Protoc. Hum. Genet."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2025.103679","article-title":"Massive expansion and cryopreservation of functional human induced pluripotent stem cell-derived cardiomyocytes","volume":"6","author":"Maas","year":"2025","journal-title":"STAR Protoc."},{"key":"10.1016\/j.bioactmat.2026.04.032_bib57","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1161\/CIRCRESAHA.119.315491","article-title":"Generation of quiescent cardiac fibroblasts from human induced pluripotent stem cells for in vitro modeling of cardiac fibrosis","volume":"125","author":"Zhang","year":"2019","journal-title":"Circ. Res."}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26002343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26002343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T07:36:48Z","timestamp":1790408208000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X26002343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":57,"alternative-id":["S2452199X26002343"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.04.032","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling ventricular tachycardia in genetic long QT syndrome using engineered cardiac tissues","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.04.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}